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l. Introduction
1.1 Metabolic engineering
The use of renewable feedstocks as a starting material for the production of a wide
range of value-added chemicals, so called "biorefinery", has been one of the most
outstanding issues in building of a sustainable sociefy (Rohlin et al., 2001;
Stephanopoulos et al., 2007). Considerable research effort has been exerted to
improve the economy of current microbial fermentation-based biorefinery processes.
The optimization of the metabolic flux of microbial cells by enhancing the expression
levels of desired genes anilor by depleting those of undesired ones has emerged as a
powerful strategy to improve microbial cells, called as "metabolic engineering"
(Stephanopoulos ef al., 1993).
In the past few years, metabolic engineering strategies have been widely employed
in the production of various non-natural metabolites that are useful biofuels, bulk
chemicals and pharmaceuticals. Atsumi et al. demonstrated that a series of alcohol can
be synthesized from corresponding 2-keto acids which are intermediates of amino acid
biosynthesis, by heterologous expression of an enzyme couple of 2-keto-acid
decarboxylase and alcohol dehydrogenase in Escherichia coli. The engineered E. coli
strains are capable of producing higher alcohols including isobutanol, l-butanol,
2-methyl-l-butanol, 3-methyl-l-butanol and 2-phenylethanol from glucose (Atsumi er
al., 2008). Xia et a/. used metabolically engineered E. coli strains to produce
native-size recombinant spider silk protein. In their work, a 284.9 kDa recombinant
protein of the spider Nephila clavipes is produced and spun into a fiber displaying
mechanical properties comparable to those of the native silk (Xia et a|.,2010).
Thus, metabolic engineering has been demonstrated to be a powerful strategy to
produce value-added biomolecules. Nevertheless, these attempts often suffer from
flux imbalances as artificially engineered cells typically lack the regulatory mechanisms
characteristic of natural metabolism (Kwok, 2010). Atsumi et al. transferred an
essential set of enzvmes derived from Clostridium acetobutylicum to E. coli for
l-butanol production. However, owning to the imbalanced metabolic flux and
existence of branched metabolic pathways, the butanol production was restricted
(Atsumi et a1.,2008). Additionally, the production of non-natural biomolecules such
as biofuels often raises the problem of stress on the cell due to the solvent toxicity.
1.2 Synthetic metabolic engineering
The concept of cell-free bioconversion originated when Eduard Bucher discovered
the cell-free metabolism more than 100 years ago. In 1985, Welch and Scopes
reconstructed a glycolytic pathway using individually purified yeast enzymes. The
reconstructed pathway is capable of converting 1 M (18% [w/v]) glucose to ethanol
within 8 h with nearly 100% molar yield (Welch and Scopes, 1985). Zhang et ol.
constructed a synthetic enzymatie pathway for H2 production from starch and water by
using 13 purified enzymes (Zhang et a|.2007). In their work, hydrogen yields higher
than the theoretical limit (4 H2 glucose-'; of anaerobic fermentations was obtained and
H2 production can be achieved from starch at a maximum volumetric production rate of
approximately 0.5 mM h-r. Nevertheless, little attention has been paid to the practical
application of in production systems mainly owing to the economical
unprofitability of processes involving enzyme purification. Low-cost production of
stable biocatalytic modules with high total turn-over number (TTN) value is a crucial
issue for the industrialization of enzymatic conversion processes, and thus
employment of highly stable enzymes would be a promising approach for
ッカ7り
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preparation of building blocks for in vitro synthetic biology projects (Zhang, 2010;
Zhanget a1.,2010).
Recently, thermophilic enzymes have been increasingly used in bioindustrial
processes owing to their extraordinary operational stability at high temperature and
denaturant tolerance (Demirjian et al., 2001; Niehaus et al., 1999). Most of these
applications utilize recombinant thermostable enzymes that have been expressed in
mesophilic hosts. Depending on the type of applications, thermostable enzymes have
been prepared to be cell-free (crude, partially purified or homogenous) or
cell-associated (Turner et a1.,2007). However, to the best of our knowledge, there has
been no report on the development of simple methodologies to combine multiple
thermostable catalytic modules for constructing in vitro metabolic pathways.
In this thesis, the author proposed a novel, simple technology, which was
designated as "synthetic metabolic engineering". The basic strategy of synthetic
metabolic engineering is assembly of multiple thermo-tolerant biocatalytic modules, to
construct in vitro artificial pathways for the production of desired products.
Recombinant DNA techniques allow the heterologous overproduction of thermophilic
enzymes in meSophilic microorganisms (e.g., E. coli). The use of recombinant
mesophiles having thermophilic enzymes at high temperatures results in the
denaturation of indigenous enzymes and the minimization of unwanted side reactions.
Consequently, highly selective thermophilic biocatalytic modules comparable to the
purified enzymes can be readily obtained without costly and cumbersome procedures
for enzyme purification (Honda et al., 2010; Restiaway et al.,20l l). Compared with
the conventional metabolic engineering, synthetic metabolic engineering enables us to
rationally combine those biocatalytic modules, which makes it possible to construct rn
vitro synthetic metabolic pathways specialized for chemical manufacturing. More
importantly, the excellent stability of thermophilic enzymes can mitigate the major
disadvantage of in vitro enzymatic conversion systems, namely the inability of protein
synthesis and renewal. Restiawaty et a/. constructed an ATP-regenerating system
using a heat-treated E. coli recombinant strain overproducing thermostable
polyphosphate kinase. By coupling this system with a thermostable glycerol kinase,
80 mM of glycerol 3-phosphate could be produced from 100 mM of glycerol with a
molar yield of 80% (Restiawaty et a1.,2011). Similarly, Honda et al. demonstrated an
artificial bio-synthetic pathway with ATP regeneration can be constructed and available
for the production of 2-deoxyribose 5-phosphate from fructose by using a mixture of six
heat-treated E. coli recombinant strains overproducing thermophilic enzymes from
Thermws thermophilus (Honda et a1.,2010).
Compared with conventional fermentation processes, synthetic metabolic
engineering would offer a number of potential advantages, such as better process
flexibility, elimination of tight transcriptional regulation, and easy optimization of
production processes by altering enzyme levels. The absence of a culture medium can
markedly simplify the isolation and purification of the product of interest. Moreover,
the elimination of microbial growth and byproduct formation would allow us to obtain
stoichiometrical conversions as well as an ability to perform thermodynamic predictions
of production yield.
To construct an artificial synthetic pathway by synthetic metabolic engineering,
four key steps are included: 1) appropriate selection of thermostable enzymes; 2)
expression in mesophilic hosts (e.9., E. coli); 3) preheating of the cell suspension at
high temperature (typically at 70oC for 30 min) to disrupt the cell membrane and to
inactivate the indigenous host enzymes; and 4) rational combination of those catalytic
modules at adequate ratio to achieve the stoichiometrical conversion (Fig. 1.1).
Thermophiles & Hyperthermophiles
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Step 4: Construction of an in vitro metabolic pathway by the
biocatalytic modules
Fig. 1.1 Schematic illustration of the basic procedure of synthetic metabolic
engineering
Overyiew of the present study
This thesis proposed a novel and simple technology, designated as "synthetic
metabolic engineering" and demonstrated its application to construct a
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1。3
non-ATP-forming chimeric Embden-Meyerhof (EM) pathway for the production of
desired metabolites. Overall of the present study is as follows:
The chapter 2 describes the construction of a non-ATP-forming EM pathway by
synthetic metabolic engineering and its application to lactate production. The chimeric
EM pathway was constructed by using a mixture of nine different recombinant E. coli
strains, each one of which overproduces one of seven glycolyic enzymes of Z
thermophilzs, the cofactor-independent PGM (iPGM) of Pyrococcus horikoshii, or the
non-phosphorylating glyceraldehyde-3-phosphate dehydrogenase (GAPN) of
Thermococcus kadakorensis. By coupling this chimeric EM pathway with the Z
thermophilus malatellactate dehydrogenase, a stoichiometric amount of lactate could be
produced from glucose with an overall AIP turnover number of 31.
The chapter 3 deals with malic-enzyme-mediated HCOI- fixation by synthetic
metabolic engineering. The reversible carboxylation of pynrvate catalyzed by a malic
erlzyme (AG0'= +7.3 kJ mol-r) was coupled with the thermodynamically favorable
non-AlP-forming EM pathway to balance the consumption and regeneration of redox
cofactors and to shift the overall equilibrium towards malate production (glucose + 2
HCO:- + 2H+ -+ 2 malate + 2HzO; AGO': -121.4 kJ mol-r). The malic enzyme from Z
kodaknrensls was shown to exhibit both pyruvate carboxylation (pyruvate + HCO3- +
NADPH + 2 H* --+ malate + NADP" + HzO) and pyruvate reduction (pyruvate +
NADPH + H* 
- 
lactate + NADP*) activities. The reaction specificity of ZfrME can be
redirected by increasing the HCO:- concentration. As a result, direct conversion of
glucose to malate can be achieved with a molar yield of 60%.
The conclusions and future prospectives are given in the chapter 4.
2. Construction of a non-ATP-forming Embden-Meyerhof pathway
and its application in lactate production
2.1 Introduction
Glycolysis is one of the most universal metabolic pathways and occurs in nearly all
organisms. In 1985, Welch and Scopes reconstructed a glycolytic pathway using
individually purified yeast enzymes (Welch and Scopes, 1985). Through the
reconstructed pathway, I M (18% [w/v]) glucose can be converted to ethanol within 8 h
with nearly l00o/o molar yield. In their work, they demonstrated that the imbalance of
ATR which impedes the complete conversion of glucose to ethanol, can be prevented by
adding excess amount of arsenate the reaction mixture.
Glyceraldehyde-3-phosphate (GAP) dehydrogenase (GAPDH) can accept arsenate
instead of phosphate to form 1-arseno-3-phosphoglycerate, which is simultaneously
broken down to arsenate and 3-phosphoglycerate (3-PG). A similar experiment using
a cell-free extract of Zvmomonas mobilis resulted in the conversion of 2 M slucose to
3.6 M ethanol (Algar and Scopes, 1985). The final ethanol concentration (nearly 20o/o
10
[v/v]) was higher than any natural fermentation system can achieve, indicating the
potential applicability of in vitro metabolic system.
As can be seen from Welch and Scope's work, the prevention of cofactor depletion
is a critical issue in constructing a synthetic metabolic pathway (Welch and Scopes,
1985). ATP and NAD(P)H are the most important biological phosphate and electron
donor, respectively, as they are required for numerous enzymatic reactions in both
anabolic and catabolic metabolisms. One of the possible strategies to prevent cofactor
depletion is the integration of suitable cofactor-regeneration enzymes into a synthetic
pathway. For instance, ATP regeneration systems using thermophilic polyphosphate
kinase and polyphosphate have been developed and applied to the production of
D-alanyl-D-alanine (Sato e/ al.,2007) and fructose 1,6-bisphosphate (lwamoto et al.,
2007). Thermophilic NAD(P)*-dependent 6-phosphogluconate dehydrogenase (Wang
and Zhang, 2009), glycerol dehydrogenase (Yao and Mikkelsen, 2010), and lactate
dehydrogenase (Wichmann and Vasic-Racki, 2005), are available for NAD(P)H
regeneration. However, these cofactor-regeneration systems require an exogenous
substrate serving as a phosphate and electron donor.
Rapidly expanding genomics and metabolomics information has revealed a great
diversity of microbial metabolisms. In fact, although the central metabolic routes of
bacteria and eukaryotes are generally well-conserved, variant pathways consisting
several unique enzymes with unusual cofactor specificities have been developed
archaea (Verhees et a1.,2003). For instance, the modified EM pathway of Pyrococcus
furiosus has only four orthologues of the l0 glycolysis enzymes in bacteria and
eukaryotes: triosephosphate isomerase (TIM), phosphoglycerate mutase (PGM), enolase
(ENO), and pyruvate kinase (PK) (Dandekar et al., 1999). Glucokinase (GK) and
phosphofructokinase (PFK) of P. furio,sus are ADP-dependent enzymes that are not
related to the classical ATP-dependent kinases involved in the bacterial/eukaryotic EM
pathway (Kengen et al.,1995; Tuininga et al.,1999). Although the conversion of GAP
into 3-PG is catalyzed by the enz;1laire couple of the NAD*-dependent GAPDH and the
ATP-generating phosphoglycerate kinase (PGK) in the classical EM pathway, the GAP
ferredoxin oxidoreductase (GAPOR) is responsible for the single-step phosphate
independent conversion of GAP into 3-PG in P. furiosns (Mukund and Adams, 1995).
A variant enzyme, non-phosphorylating GAPDH (GAPN), that utilizes NAD* and/or
NADP* as the cofactor for the phosphate-independent oxidation of GAP has also been
found and characterized in several archaeal strains involving Thermoproteus tenax
(Brunner et al., 1998), Sulfolobus solfataricus (Ettema et a1.,2007), and T. kodakarensis
(Matsubara et al.,20ll). The substitution of GAPDH and PGK of the classical EM
Of
ln
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pathway by archaeal GAPN theoretically enables the construction of a chimeric
pathway, in which the consumption and regeneration rates of ATP and ADP are balanced
(Fig.2.l). Moreover, GAPN can bypass the production of the extremely thermolabile
intermediate 1,3-bisphosphoglycerate (Ettema et al., 2007). Meanwhile, the glucose
oxidation via the chimeric EM pathway yields the reducing equivalents in the form of
NAD(P)H. To demonstrate the feasibility of the chimeric EM pathway, a
NADH-dependent malatellactate dehydrogenase was employed to achieve the redox
balance ofthe cofactor and direct conversion from slucose to lactate.
Lactate has been attracting a great attention for its application in food, cosmetic,
pharmaceutical and chemical applications (Dumbrepatil et a1.,2008). However, in the
conventional lactate fermentation process, fermentation broth contains impurities such
as color, residual sugars, nutrients, and other organic acids, apart from cell mass
(Joglekar et ol., 2006). Many studies concerning lactate separation using different
techniques such as direct distillation, solvent extraction, adsorption and electrodialysis,
have been conducted in order to reduce the operating cost (Kim and Moon,200l).
Synthetic metabolic engineering without the use of a culture medium would markedly
simplify the isolation and purification of lactate.
13
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Fig. 2.1 Schematic illustration of design of chimeric Embden-Meyerhof (EM)
pathway. The bacterial/eukaryotic classic EM pathway (left), modified EM pathway
of Thermococcales archaea (center), and chimeric EM pathway constructed in this study
(righD are illustrated. Reactions catalyzed by enzymes uniquely involved in the
archaeal modified EM pathway are indicated by grey arrows. Abbreviations used: G6P,
glucose-6-phosphate; F6P, fructose-6-phosphate; FBP, fructose-1,6-bisphosphate; GAP,
glyceraldehyde-3-phosphate; DFIAP, dihydroxyacetone phosphate; 1,3-BPG,
1,3-bisphosphoglycerate; 3-PG, 3-phosphoglycerate; z-PG, 2-phosphoglycerate; PEP,
phosphoenolpynrvate; GK, glucose kinase; PGI, glucose-6-phosphate isomerase; PFK,
6-phosphofructokinase; FBA, fructose-bisphosphate aldolase; TIM, triosephosphate
isomerase; PGM, phosphoglycerate mutase; ENO, enolase; PK, pynrvate kinase;
MLDH, malate/lactate dehydrogenase, GAPOR, glyceraldehyde-3-phosphate ferredoxin
oxidoreductase; GAPN, non-phosphorylating glyceraldehyde-3-phosphate
dehydrogenase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; PGK,
phosphoglycerate kinase; Fdo*, oxidized ferredoxin; and Fd66, reduced ferredoxin.
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2.2 Materials and methods
2.2.1 Bacterial strain and plasmid
The expression vectors for genes encoding GK, PGI, PFK, FBA, TIM, ENO, PK,
and MLDH of T. thermophilus HB8 were obtained from the Riken Thermus
thermophilzs HB8 expression plasmid set (Yokoyama et a1.,2000). The expression
vector for GAPN (Matsubara et al.,20ll) was a kind gift from Professor H. Atomi of
Kyoto University. The gene encoding iPGM was amplified by PCR from the
chromosomal DNA of Pyrococcus horikoshii OT3 (Takara Bio) with the following
primers: 5'-TTQAIA|SGTGCTA,rA'r{GAGGA,TA'AGGC-3' (the NdeI restriction site is
underlined) and 5'-TTGAAITCTCAAGCTCCA,TA.ATTTTTCGCTCCT-3' (the EcoRl
restriction site is underlined). The amplified DNA was digested with NdeI and EcoRl
and inserted into the corresponding restriction sites of pET2la (Novagen).
E. coli Rossetta2 (DE3) (Novagen) was used as a host strain for gene expression.
The recombinants were aerobically cultivated in Luria-Bertani (LB) media containing
100 pg ml-r ampicillin and 34 pg ml-r chloramphenicol at 37oC. Gene expression was
induced by an addition of 0.2 mM isopropylthiogalactoside (IPTG) to late-log culture
15
for 4 h. Cells were harvested by centrifugation and resuspended in 50 mM
HEPES-NaOH buffer GH 7.0). The cell suspensions were heated at 70oC for 30 min
before being used for lactate production.
2.2.2 Enzyme assays
E. coli cell suspensions
Osaka, Japan), and the crude
were disrupted with a UD-201 ultrasonicator (Kubota,
lvsate was heated at 70oC for 30 min. Cell debris and
denatured proteins were removed by centrifugation at 15,000 rpm and 4oC for 10 min.
The supematant was then used as an enzyme solution. Protein concentration was
measured with the Bio-Rad assay system (Bio-Rad, Hercules, CA, USA) using bovine
serum albumin as the standard.
One unit of the enzyme was defined as the amount consuming I pmol of the
substrate per min under the assay conditions. The standard assay mixture for GK was
composed of 50 mM HEPES-NaOH (pH 7.0), 0.1 mM glucose, 0.2 mM ATR 5 mM
MgCl2, 0.5 mM MnClz, I mM NAD-, I mM GlR 0.08 U of PGI, 0.2 U of PFK, I U of
FBA, 0.1 U of TIM, 0.02 U of GAPN, and an appropriate amount of GK. The mixture
without glucose was preincubated at 50oC for 2 min, and then the reaction was initiated
16
by an addition of 0.1 mM glucose. The reduction of NAD- was monitored at 340 nm
using a UV-VIS spectrophotometer (Model UV2450, Shimadzu, Kyoto, Japan).
Similarly, the activities of PGI, PFK, FBA, TIM, and 'GAPN were
spectrophotometrically assessed in the mixture containing the substrate for each enzyme
(0.1 mM of glucose-6-phosphate, fructose-6-phosphate, fructose-1,6-bisphosphate,
dihydroxyacetone phosphate, or 0.2 mM GAP, respectively) instead of glucose.
iPGM activity was assayed at 50oC in a mixture consisting of 50 mM
HEPES-NaOH (pH 7.0),0.2 mM 3-phosphoglycerate, 5 mM MgCl2, 0.5 mM MnClz,
0.2 mM ADP, 0.2 mM NADH, 0.5 U of ENO, 0.5 U of PK, 1.2 U of LDH, and an
appropriate amount of enzyme. ENO and PK were assayed in the same manner using
0.2 mM of 2-phosphoglycerate and phosphoenolpyruvate as the substrate, respectively.
The activities of LDH and MLDH were assessed at 50oC by mixing the enzymes
with 50 mM HEPES-NaOH (pH 7.0), 5 mM MgCl2, 0.5 mM MnCl2, 0.2 mM NADH,
and 0.2 mM pyruvate. NADH oxidation was monitored at 340 nm.
The heat-treated cell lysate of the recombinant E. coli harboring an empty vector
showed no detectable level of activity under the assay conditions.
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2.2.3 Lactate production
The reaction mixture (4 ml) was composed of 0.1 mM glucose, 0.2 mM 3-PG, 0.2
mM pyruvate, 5 mM MgCl2, 0.5 mM MnClz, 0.2 mM ATR 0.2 mM ADR I mM NAD*,
0.2 mM NADH, 1 mM GlP, and 50 mM HEPES-NaOH buffer (pH 7.0). The cell
suspensions of E. coli producing GK, PGI, PFK, FBA, TIM, GAPN, iPGM, ENO, PK,
and MLDH were preheated at 70oC for 30 min and then added into the reaction mixture
atfinalconcentrationsof 2, l, l, l, l,26,3,3,3, and 100mg(wetweightcells)/ml,
respectively. The reaction mixture was stirred in a container kept at 50oC, and glucose
solution (40 mM) was added to the mixture at a flow rate of I pl min-' (: 0.01 pmol
ml-r min-l) using a Shimadzu LC-}}AD solvent delivery unit. Aliquots (50 pl) of the
reaction mixture were withdrawn at I h intervals, diluted fourfiold with distilled watet
and centrifuged to remove the cell debris (15,000 rpm, l0 min). The supernatant was
then ultrafiltered using Amicon 3K (Millipore) and analyzed by a high-perforrnance
liquid chromatography (HPLC).
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2.2.4 Analytical methods
Lactate and pyruvate were quantified by HPLC on two tandemly connected ion
exclusion columns (Shim-pack SPR-H,250 mm x 7.8 mm, Shimadzu). The columns
were eluted at 50oC using 4 mM p-toluenesulfonic acid as a mobile phase of at a flow
rate of 0.3 ml min-r. The eluent was mixed with a pH-buffered solution (16 mM
Bis-Tris, 4 mM p-toluenesulfonic acid, and 0.1 mM EDTA) supplied at a flow rate of
0.3 ml min-l, and then analyzed for lactate using a conductivity detector (CDD-2OA,
Shimadzu, Kyoto, Japan). NAD* and NADH concentrations were analyzed
colorimetrically using a NADA{ADH quantification kit (Biovision, Mountain View, CA,
USA) in accordance with the procedure provided in the kit. ATP and ADP
concentrations were assessed quantitatively using the Enzylight ADP/ATP ratio assay
kit (BioAssay Systems, Hayward, CA, USA) according to the manufacturer's
instructions
2.3  Results
2.3.1 Selection of enzymesfor chimeric EM pathway
19
GAPN, a key enzyme for constructing a chimeric EM pathway, was derived from
the hyperthellllophilic archaeon r′あdα′″″,,sお. Although both NAD+and NADP+
can serve as the electron acceptor, the Kn, of Thermococczs GAPN for NADP* is two
orders of magnitude lower than that for NAD* (Matsubara et al., 20ll). However, the
thermostability of NADP* is considerably lower than that of NAD*, particularly under
neutral and acidic conditions (Wu et al., 1986). Owing to this fact, NAD* was
employed as the redox cofactor for the construction of a chimeric pathway. The
erzyme can be strongly activated by the addition of glucose-l-phosphate (GlP)
(Matsubara et al.,20ll). Under the assay conditions employed in this study, GAPN
exhibited the highest specific activity in the presence of GIP at 100 pM or higher.
The thermophilic bacterium T. thermophilzs HB8 was used as the source of other
genes required for the construction of a chimeric pathway. Among them, the
cofactor-independent phosphoglycerate mutase (iPGM) showed a relatively low thermal
stability (Fig. 2.2). Although the thermal inactivation of other enzymes was
insignificant, the activity of the Thermus iPGM was lost almost completely after the
incubation of the enzymes at 50oC for 2 h. The author then isolated and
heterologously expressed the gene encoding iPGM from a hyperthermophilic archaeon,
P. horikoshii, exhibiting a higher optimum growth temperature (98"C) (Gonzillez et al.,
20
1998) than that of T. thermophilus (70"C) (Oshima and lmahori,1974). Although the
specific activity and thermal stability of the Pyrococcus iPGM were not markedly
different from those of Thermus enzyme, they were considerably improved by the
addition of Mn2* (Fig.2.2). This finding was in good agreement with a previous report
that the thermal stability of iPGM from the thermophilic archaeon Archoeoglobus
fulgidus, which shares a 47.5o/o amino acid sequence identity with the Pyrococcus
enzyrne, can also be improved by an addition of Mn2* (Johnsen et a1.,2007). On the
basis of these results, Pyrococczs iPGM was employed and used it in the presence of
Mn2*.
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Some bacterial lactate dehydrogenases are inhibited by ATP and/or NAD", and thus
play an important role in the allosteric regulation of the flux of glycolysis (Garvie,
1980). Although the inhibitory effect of ATP (up to I mM) was almost negligible, the
addition of 0.1, 0.2, and I mM NAD* caused 6Q, 76, and 95%o decreases in the activity
of Thermus lactate dehydrogenase compared with that under the standard assay
conditions, respectively (Fig. 2.3). Owing to the low affinity of GAPN to NAD', the
chimeric pathway, therefore, required a certain amount of exogenous NAD-. This
limitation led the author to search for another enzyme that catalyzes the reduction of
pyruvate to lactate. A putative NAD(P)H-dependent dehydrogenase, which was
annotated as malate/lactate dehydrogenase (MLDH), was found in the gene-expression
library of T. thermophilus HB8 (Yokoyama et a1.,2000). The enzyme was confirmed
to show pyruvate reducing activity with no inhibitory effect by NAD* or other
metabolic intermediates in this pathway (Fig. 2.3). The natural substrate of this
enzyme was unknown and it might more preferably accept metabolite other than
pyruvate in physiological conditions. However, the in vitro synthetic pathway
involves only a limited number of necessary metabolites, and thus an enzyme with
broad substrate specificity is also available. More importantly, the allosteric regulation
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of the pathway flux can be eliminated by assembling enzymes derived from distinct
organisms or metabolic pathways.
I
NAD* (mM)
Fig. 2.3 Inhibitory effect of NAD+ on activities of lactate dehydrogenase (empty
circle) and malatellactate dehydrogenase (solid circle) of T. thermophilus. The assay
was performed at 50oC in the mixture composed of 50 mM HEPES-NaOH (pH 7.0), 0.2
mM pyruvate, 0.2 mM NADH, an appropriate amount of enzyme, and the indicated
concentration of NAD*. After the preincubation for 2 min at 50oC, the reaction was
initiated by an addition of pyruvate.
2.3.2 Optimization of reaction conditions
One of the major advantages of in vitro metabolic pathways is the flexibility of the
reaction conditions. As long as the enzymes exhibit acceptable activities, reaction
conditions can be freely adjusted and optimized. All the enzymes used to construct the
chimeric EM pathway exhibited their maximum activity at 60oC or higher (Fig. 2.aA).
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However, the degradation of cofactors as well as the thermostabilities of some
intermediates of the EM pathway, particularly those of GAP, DHAP, and PEP, became
significant at 60oC or higher (Fig. 2.aB). Consequently, the reaction temperature of
50oC was chosen as a compromise between the thermostability of intermediates and
enzyme activity. The specific activities of the crude extracts of E. coli recombinants
harboring each enzyme were assessed at various pH (Table 2.1). On the basis of the
pH profiles of each erzymq the total protein concentrations of the enzyme mixture
(containing 0.01 U each of GK, PGI, PFK, FBA, and TIM, along with 0.02 U each of
GAPN, iPGM, ENO, PK, and MLDH) was found to be minimized at pH 7.0 (Table 2.1).
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Fig. 2.4 Effects of temperature on enzyme activity and thermal stability of
intermediates and cofactors involved in chimeric EM pathway. (A) The enzyme
activities were determined under the standard assay conditions (ffiPES-NaOH, pH 7.0)
at indicated temperatures. Specific activities were given as those in the crude extract
of recombinant E coli having each enzyme. One unit was defined as the amount of
erlzyme catalyzing the consumption of I pmole of the substrate per minute. (B) The
intermediates and cofactors were dissolved in 50 mM HEPES-NaOH (pH 7.0) and
incubated for I h at 0, 40, 50, 60, and 70oC. The residual concentration of
intermediates was determined by CE-TOFMS (Itoh et a\.,2004). ATP, ADP, NAD*,
and NADH (0.1 mM) were determined as described in2.2.4.
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Table 2.1 Effects of pH on enzyme activity1
2
3
4
5
6
7
Buffer pH
Specific activity
(U mg-t total protein) u
Total protein concentration
(mg ml‐
1)b
PGI PFK FBA TIヽ4 GAPN  iPGMENO MLDH
?
?
?
?
?
?
?
?
?
?
MES
MES
HEPES
HEPES
Biclne
Biclne
CHES
CHES
0.19  7.6
3.7    7.3
2.9   2.3
5.1  11
4.5    16
7.5    14
6.0   14
2.6  6.1
6
7
7
8
8
9
9
10
4.9
18
8.8
8
15
8
30
10
7.3   9.2   0.030
7.3   17    0.039
6.9   13    0.036
6.5   5,0   0.042
4.0   2.1   0.035
2.4   0.07  0.041
4.4   0.9   0.031
4.6   2.3   0.0051
0.11
0.17
0.2
0.087
0.078
0.035
0.017
0.0 75
1.1
2.6
3.1
1.2
1.3
0.66
0.40
0,10
9.4    0.0026
5.2     0.013
4.5     0.019
0.65   0.014
1.0    0.011
0,42   0.012
0.19   0.0095
0.047  0.0021
8.6
2.2
1,7
2.2
2.7
3.0
4.1
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uThe specific enzyme activities in the crude extract of recombinant E. coli were determined under standard assay conditions (50oC) at
indicated pHs.
bThetotal protein concentration of the mixture of crude extracts containing the essential enzyme titer (0.01 U each of GK, PGI, PFK,
FBA, and TIM, and 0.02 U each of GAPN, iPGM, ENO, PK, and MLDH) was estimated.
26
2.3.3 Real-time estimation of production rate
For the real-time estimation of production rate, the whole pathway was divided in
two parts; l) the top part (glucose to 3-PG) and2) the bottom part (3-PG to lactate).
The former part, involving GK, PGI, PFK, FBA, TIM, and GAPN, catalyzed the
conversion of glucose to 3-PG with concomitant NADH production, which could be
spectrophotometrically monitored at 340 nm. On the basis of the enzyme activities,
which were individually determined under standard assay conditions, essential units of
enzymes (i.e., 0.07 U each of GK, PGI, PFK, FBA, and TIM, and 0.02 U of GAPN)
were incubated with 0.1 mM glucose at pH 7.0 and 50oC. The initial NADH
production rate observed under these conditions, however, was considerably lower
than the expected value of 0.02 pmol ml-l min-I. The expected production rate could
be achieved by increasing the units of PFK, FBA and GAPN to 0.2, 1 and 0.03 U,
respectively. In the constructed pathway, the actual concentrations of the respective
metabolites were kept at lower levels than those used in the standard assay conditions.
Consequently, the reaction rates of each enzyme, especially those with relatively high
K,n value for their substrates, were lower than those observed under standard assav
conditions. Larger amounts of the enzymes were, therefore, required to achieve the
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expected production rate. Similarly, the NADH consumption rate of the bottom part
(from 3-PG to lactate) was determined with an initial 3-PG concentration of 0.2 mM.
The NADH could be consumed at a rate of 0.02 umol ml-l min-r in the mixture
containing 0.02 U each of iPGM, ENO, PK, and MLDH. By this way, the essential
amounts of enzymes constituting the top and bottom parts of the synthetic pathway
were experimentally determined.
2.3.4 Lactate production by chimeric pathway
All the enzymes employed in this study were heterologously produced in E. coli
Rosetta2 (DE3) under control of the T7 promoter in the native form with no additional
tag sequence. The recombinant cells were suspended in 50 mM HEPES-NaOH buffer
(pH 7.0) and preheated at 70oC for 30 min to disrupt the cell membrane and to
inactivate E. coli enzymes. Lactate production using the chimeric pathway was
performed directly using a mixture of heat-treated recombinant cells with the
experimentally determined amounts of enzymes to achieve a production rate of 0.02
pmol ml-1 min-l.' Addition of glucose to the reconstituted pathway at an inadequate
dose was suspected to result in an uncontrolled glucose phosphorylation. As excess
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glucose feeding causes a rapid glucose phosphorylation by GK, insufficient ATP for
the further phosphorylation of F6P catalyzed by PFK would be observed as a result.
By contrast, lower feeding rate would result in a decrease in lactate production rate.
Thus, unlike the use of living microbial cells, in which glucose uptake rate is regulated
by specific glucose transporters (Meadow et al., 1990; Postma et al., 1993), the
optimization of substrate feeding rate is necessary for the operation of the reconstituted
pathway. As expected, the molar yield of lactate production decreased when the
feeding rate exceeded 0.01 pmol ml-r min-r 1Fig. 2.5A). The obtained yield which
was slightly higher than theoretical yield was likely attributed to an addition of
intermediates (0.1 mM glucose,0.2 mM 3-PG and 0.2 mM pyruvate) into the reaction
mixture, performed in order to achieve the constant production rate during the reaction.
At a feeding rate of 0.01 pmol ml-l min-I, production rate remained constant at its
expected value (0.02 pmol ml-r min-i; during the initial 5 h, and approximately 6 mM
of lactate was produced from 3 mM of glucose (Fig. 2.5B, black circle). However,
production rate started to decrease after 5 h, and the molar yield of lactate production
rapidly dropped to 58% at 10 h (Fig. 2.5B, empty circle). Concurrently, pyruvate
accumulation was detected. Whereas the thermal inactivation of all enzyrnes
involved in the chimeric pathway was insignificant after the incubation at 50oC for I0
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h, the thermal decomposition of both NAD* and NADH, particularly NADH, was not
negligible (Fig. 2.5B, squares). The depletion of the cofactor likely caused a decrease
in the catalytic performance of MLDH. Moreover, the rate of the GAPN-mediated
reaction was particularly sensitive to the depletion of the cofactor owing to its
relatively high K. for NAD*. A decrease in the rate of the GAPN-mediated reaction
led to the accumulation and decomposition of the thermolabile intermediates GAP and
DHAP, and to a decrease in the overall lactate production yield. Lactate production
rate was recovered bv addition of I mM NADH after the reaction for 5 h. The final
lactate concentration reached 12 mM with an overall production yield of 100% at 10 h.
From the actual AIP and ADP concentrations of the reaction mixture (0.4 mM), the
ATP tumover number was calculated to be 31. The ATP tumover number was defined
as moles of the product formed per moles of the cofactor added. The effect of
cell-derived endogenous AIP and ADP (0.37 pM) was considered to be negligible.
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ATotal glucose (mM) LaCtate(mM) Yleld(%)
Feeding rate=0.04 prnd ml■minJ
1         2.4
2        4.8
Feeding rate=0.02 11mol mi・l min・1
1              1.2
2             24
FeediⅢg rlte=0.01 1LmOl mi-l min-1
0,6
112
1.54=0.31
1.59±0.52
2.17±0153
3.22=0,08
1.45■0123
2.48‐士10126
32.2
16.6
905
67:2
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Fig. 2.5 Lactate production via chimeric EM pathway. (A) The lactate production
was performed as described in Materials and methods with glucose feeding at indicated
rates. After the reaction for I and 2h,lactate concenffation was determined by HPLC,
and yield on glucose (o/o mollmol) was calculated. (B) Time course of lactate
production at a glucose feeding rate of 0.01 pmol ml-l min-r (circle). The total
concentration of NAD+ and NADH are indicated by square symbols. Lactate and
NAD(H) concentrations with or without an additional NADH supplement (1 mM) after
the initial 5-h reaction are shown by solid and empty symbols, respectively.
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2.4 Discussion
In this work, a glycolytic pathway with no net ATP yield was constructed by
chimerically integrating the archaeal GAPN to a classical EM pathway. The synthetic
pathway produced a stoichiometric amount of lactate from glucose with an overall ATP
tumover number of 31 . Note that such a non-ATP-forming glycolysis pathway could
no longer play a physiological rcle (i.e., energy production particularly under
anaerobic conditions) and thus would not be applicable for a fermentative purpose lr
vivo. In fact, although the GAPDH defect of E. coli can be complemented with the
Pisum sativum GAPN under aerobic condition, this recombinant strain fails to grow
anaerobically (Valverde et al., 1999).
Although the author demonstrated that the endogenous ATP regeneration could be
achieved, the thermolability of NADH remained a major obstacle for the long-term
operation of a synthetic metabolic system. A possible alternative to overcome this
limitation is the replacement of NADH with more stable and low-cost artificial
biomimetic NADH analogs (Ansell and Lowe, 1999). Protein engineering
approaches to improve the affinities of enzymes to these NADH biomimics may be
also required (Ryan et a|.,2008). Another important issue that should be resolved is
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the increase in production rate. Although it was predicted to increase proportionally
along with a total enzyme concentration (Tuesink et a1.,2000), the total amount of
enzymes required to obtain a desired rate is often not practically achievable. On the
other hand, naturally occurring cellular apparatus, in which a series of metabolic
enzymes are packed in close proximity, can reduce the intermediate diffusion distance
and therefore increase the overall reaction rate. The coexpression of thermophilic
enzymes constituting a synthetic pathway in a single recombinant will be an effective
strategy to spatially organize the enzymes and achieve a high production rate (Conrado
et a|.,2008).
2.5 Summary
A chimeric EM pathway was constructed by synthetic metabolic engineering using
a mixture of nine different recombinant of E. coli strains, each one of which
overproduces either one of seven glycolytic enzymes of T. thermophilus, the iPGM of
P. horil<oshii, or the GAPN of T. kodalarensis. By coupling this chimeric EM
pathway with the T. thermophilus malate/lactate dehydrogenase, a stoichiometric
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amount of lactate could be produced from glucose with an overall ATP turnover
number of 31.
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3. Direct conversion of glucose to malate by synthetic metabolic
engineering
Introduction
With the threat of global climate change, there is a growing demand for techniques
of converting CO2 into renewable fuels and chemicals (Atsumi et a1.,2009; Li et al.,
2012). The applicability of biocatalysts to the conversion of COz to aspartate,
isocitrate, and formate has been demonstrated over the past few decades (Parkinson
and Weaver,1984; Ruschig et a1.,1976;Melzer and O'Leary,1987). COz reduction
mediated by a malic enzyme, which can catalyze the reversible carboxylation of
pyruvate to malate with the concomitant oxidation of NAD(P)H to NAD(P)+ has been
examined more extensively in recent years as a promising approach to greenhouse gas
fixation and the production of useful biocommodities (Ohno et a1.,2008; Zheng et al.,
2009).
Malate, which is a potential biomass-derivable "building block" for chemical
synthesis, has been widely used in food, cosmetic, pharmaceutical, and chemical
applications (Chibata et al., 1983; Zelle et a1.,2008). In 2004, the US Department of
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Energy included a group of 1,4-dicarboxylic acids, consisting of succinate, fumarate,
and malate, in the top 12 most interesting chemical building blocks that can be derived
from biomass (Werpy and Petersen,2004).
The use of a malic enzyme can provide a shortcut for Ca-dicarboxylic acid
production. Ohno et al. reported the fixation of HCO3- to pyruvate using a purified
malic enzyme from Pseudomonas diminuta coupled with glucose 6-phosphate and
glucose 6-phosphate dehydrogenase for NADH regeneration. The system is capable
of converting 100 mM pyruvate to 38 mM L-malate within 24 h with a 38o/o molar
yield (Ohno et a1.,2008). A similar experiment using a purified malic enzyme of
Brevundimonas diminuta conjugated with the electrochemical regeneration of NADH
on an enzyme-mediator-immobilized electrode, resulted in a nearly l.l mmol of malate
production from 12.5 mmol of pyruvate and2.5 mmol of NaHCO3 within 48h (Zheng
et a1.,2409).
It is crucial to determine the thermodynamical feasibility of carboxylation
reactions. According to the second law of thermodynamics, such reactions occur only
in the direction of the negative Gibbs energy of reaction. The oxidative formation of
malate catalyzed'by a malic enzyme (pyruvate + HCOI- + NADPH + 2H* ---+ malate *
NADP+ + HzO; AG0'= +7 .3 H mol-l; is thermodynamically unfavorable (Thauer et al.,
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1977; Goldberg et al.,1993). One of the possible strategies to solve this problem is
coupling with thermodynamically favorable NAD(P)H regeneration enzymes including
glucose I -dehydrogenase (glucose + NADP* -* glucono-1,S-lactone + NADPH + H*;
AG0' = -4.0 kJ mol-r), glucose 6-phosphate dehydrogenase (glucose-6-phosphate +
NADP+ --- glucono-l,5-lactone 5-phosphate + NADPH + H*; AG0' : -9.3 kJ mol-l;,
and 6-phosphogluconate dehydrogenase (6-phosphogluconate * NADP* --- ribulose-
5-phosphate + CO2 + NADPH + H*; AGO' : -43.6 kJ mol-r). In the chapter 2, an in
vitro thermodynamically favorable non-ATP-forming EM pathway using a mixture of
nine different recombinant E. coli strains has been constructed (glucose + Z NAD(P)*
- 
2 pyruvate + 2 NAD(P)H + 2 H*, A60': -136.4 kJ mol-l). In this pathway, GAPN,
which utilizes NAD- or NADP- as cofactors for the phosphate-independent oxidation
of GAP, was employed as a substitute for GAPDH and ATP-generating PGK. Thus,
the regeneration and consumption rates of ATP and ADP could be balanced (Ye et al.,
2012). Moreover, the glucose oxidation via the chimeric EM pathway yields the
reducing equivalent in the form of NAD(P)H. The inability of ATP formation via the
chimeric EM pathway leads to a larger negative AGo'of approximately -136 kJ mol-r
than that via the classical EM pathway, which theoretically enables the shift in the
equilibrium of malic-enzyme-mediated carboxylation.
37
In this chapter, the author aimed to demonstrate the thermodynamical feasibility of
the chimeric EM pathway for redirecting reversible carboxylation, which is catalyzed
by a NAD@)H-dependent malic enzpe derived from the hyperthermophilic archaeon
T. lrodalrnrensis (Tklffi), to achieve the direct conversion of glucose to malate (glucose
+ 2 HCOg- + Z rt -+ 2 malate + 2 HzO;AG0': -121.4 kJ mol-r) (Fig. 3. I ).
ATP
ADP HCOぎ
ATP X 2
ADPx2
NADP+x2
NADPH x 2
2
ATP
ADP
NADPH x2
NADP+x
DHAP
Fig. 3.1 Schematic illustration of design of synthetic pathway for direct conversion
of glucose to malate. ME, malic enzyme.
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3.2  Materials and lllethOdS
3.2.1 Plasmid construction and protein expression
The gene encoding TbME was amplified by PCR from the chromosomal DNA of Z
lwdakarens,s KODI (Takara Bio, Shinga, Japan) using the following primers:
5'-TTCATATGAATCCCCTCGAATTCCATAGGGA-3' (the NdeI restriction site is
underlined) and 5'-TTAAGCTTCTAGGGGGAACTCCCTCTACCG-3' (the Hindil,
restriction site is underlined). The amplified DNA was digested with NdeI and
Hindil, and inserted into the corresponding restriction sites of pET2l(a) (Novagen,
Madison, WI, USA). The resulting expression vector was transformed into E. coli
Rosseta2 (DE3) (Novagen). The expression vectors for glucokinase (GK),
glucose-6-phosphate isomerase (PGI), 6-phosphofructokinase (PFK),
fructose-bisphosphate aldolase (FBA), triosephosphate isomerase (TIM), enolase
(ENO), and pyruvate kinase (PK) of T. thermophilus, |PGM of P. horil<oshii, and
GAPN of T. ladakorensis were described previously (Ye et a1.,2012).
The recombinants were aerobically cultivated in Luria-Bertani (LB) medium
containing 100 pg ml-r ampicillin and 34 pg ml-l chloramphenicol at 37oC. Gene
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expression was induced by adding 0.2 mM IPTG to late-log culture for 4 h. Cells
were harvested by centrifugation and resuspended in 50 mM HEPES-NaOH buffer (pH
7.0). The cell suspensions were heated for 30 min at 70oC and then used for malate
production.
3.2.2 Malic enzyme assay
E. coli cells were disrupted with a UD-201 ultrasonicator (Kubota, Osaka, Japan),
and the crude lysate was heated at 70oC for 30 min. Cell debris and denatured
proteins were removed by centrifugation at 12,000 x g and 4oC for 10 min. The
supernatant was then used as the enzyme solution. Protein concentration was
measured with the Bio-Rad assay system (Bio-Rad, Hercules, CA, USA) using bovine
serum albumin as the standard. One unit of the enzyme was defined as the amount
consuming I pmol of the substrate per minute under the assay conditions.
The pyruvate carboxylation activity (malate-forming) of TbME was determined by
monitoring the decrease in NADPH concentration at 340 nm using a UV-VIS
spectrophotometer (Model UV-2450, Shimadzu, Kyoto, Japan) at 50oC. The standard
reaction mixture was composed of 500 mM HEPES-NaOH buffer (pH 7.0), 10 mM
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NruCl, 0.5 mM MnClz, 0.2 mM NADPH, 15 mM pyruvate, 80 mM NaHCOr, and an
appropriate amount of enzyme. The optimum HCO3- concentration for IftME was
determined at 50oC. The pyruvate reduction activity (lactate-forming) was subtracted
from each measurement. Pyruvate reduction activity was measured similarly at 50"C
except that the reaction mixture contained no NaHCO3 and the reaction was initiated
by adding 15 mM pyruvate.
3.2.3 Determination of carborylating species
The active carboxylating species was spectrophotometrically determined by a
modified method (Erb et a1.,2009) at l5oC, monitoring the rate of NADPH oxidation
at 340 nm. All the solutions were prepared freshly and stored on ice before use.
The carboxylation with "dissolved COz" was measured in a reaction mixture (0.1 ml)
containing 500 mM HEPES-NaOH (pH 7.0), 10 mM NH+CI, 0.5 mM MnCl2, 0.2 mM
NADPH, 15 mM pyruvate, and an appropriate amount of enzyme. To start the
carboxylation, 1.5 pl of I M NaHCO3 w&s mixed with 9 pl of I M acetic acid to
generate CO2 from bicarbonate by acidification, and this "CO2 solution" was added to
reaction mixture immediately. A "bicarbonate" solution was prepared by mixing 1.5
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pl of I M NaHCO3 with 9 pl of H2O and added to the reaction mixture immediately.
As control experiments, both reactions were performed with an appropriate amount of
human erythrocyte carbonic anhydrase (Signa-Aldrich, St. Louis, Missouri, USA).
3.2.4 Malate production coupled with glucose l-dehydrogenase at various HCO;
concentrations
The standard reaction mixture contained 500 mM HEPES-NaOH (pH 7.0), l0 mM
NruCl, 0.5 mM MnClz, I mM NADPH, I mM pyruvate, I mM glucose, 0.3 U of
glucose 1-dehydrogenase (GDH; Thermostable Enzyme Laboratory Kobe, Japan), and
an appropriate amount of ZftME. The initial concentrations of NaHCO3 added were 0,
21.3,42.5, and 85 mM. The reaction mixture was stirred in a sealed container kept at
50oC, and the headspace of the container was equilibrated with a N2 gas mixture
containing 0, 25, or 50%o CO2 gas or with 100% of COz gas for 5 min before the
addition of substrates. After the reaction for 5 h at 50oC, the mixture was ultrafiltered
using Amicon 3K (Millipore) and subjected to high-performance liquid
chromatography '(FIPLC).
42
3.2.5 Production of molatefrom glucose
The preparation of heat-treated cell suspensions was described in chapter 2 (Ye et
a\.,2012). Cell suspensions of E. coli producing GK, PGI, PFK, FBA, TIM, GAPN,
iPGM, ENO, PK, and ThME were added to the reaction mixture at final concentrations
of 1, l,1,7,1,2,5,5,5, and 5 mg (wet cell weight)/ml, respectively. The reaction
mixture (a ml) also contained 0.1 mM glucose, 0.2 mM 3-phosphoglycerate, I mM
pyruvate, 5 mM MgCl2, 0.5 mM MnClz, 10 mM NH+CI, 0.2 mM ATP,0.2 mM ADR I
mM NADP*, I mM NADPH, I mM glucose 1-phosphate, 80 mM NaHCO3, and 500
mM HEPES-NaOH buffer (pH 7.0).
The reaction mixture was stirred in a 10-ml rubber-capped reaction vessel. The
mixture was equilibrated with 100% CO2 gas for 5 min at 50oC before the addition of
the substrates. Then the vessel was further sealed with Parafilm M (Pechiney Plastic
Packaging, Chicago, USA) to prevent CO2 leakage and the mixture of 40 mM glucose
and 80 mM NaHCO: solutions was added to the reaction mixture at a flow rate of 1 pl
min-l1= 0.01 pmol ml-l min-r glucose
Shimadzu LC-20AD solvent delivery
0.02 pmol ml-r min-l NaHCOT) using a
The mixture of glucose and NaHCOI
solutions was equilibrated with 100% CO2 gas throughout the reaction. Aliquots (50
???????
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pl) of the reaction mixture were drawn, diluted fourfold with ice-chilled water, and
centrifuged to remove cell debris (15,000 rpm, l0 min,4oC). The supernatant was
then ultrafiltered using Amicon 3K (Millipore) and subjected to HPLC. NADP* and
NADPH concentrations were analyzed colorimetrically using a NADPNADPH
quantification kit (Biovision, Mountain Vew, CA, USA) in accordance with the
procedure provided in the kit. Pyruvate, malate, and lactate were quantified by HPLC
on two tandemly connected ion exclusion columns (Shim-pack SPR-H, 250 mm x 7.8
mm, Shimadzu) as described in the chapter 2.
3.3 Results
3.3.1 Characterization of recombinant ThME
Although TbME can accept both NADP- and NAD' as electron acceptors for the
oxidative decarboxylation of malate, its activity with NAD* was seven times lower
than that with NADP- (Fukuda et a1.,2005). Thus, NADP(H) was employed as tle
redox cofactor' for the construction of the chimeric pathway. [n malate
decarboxylation, recombinant TbN/E showed the highest activity at pH 8 above 90oC
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(data not shown). These results were in good agreement with the previous results
(Fukuda et a1.,2005). In the pyruvate carboxylation reaction, the optimal pH and
temperature were 6.5 and 70oC (Figs. 3.2A and 3.28). Although the enzyme was
derived from the hyperthermophilic archaeon T. kodokarensr's, whose optimum growth
temperature was approximately 85oC (Atomi et o1.,2004), the optimum temperature
for the carboxylation activity of Z&ME was much lower (70"C). This was likely
attributed to the decrease in the saturation concentration of CO2 at high temperatures.
In addition to the oxidative decarboxvlation of malate and the reductive carboxvlation
of pyruvate, TkME was found to have a pyruvate reduction activity (the reduction of
pyruvate to lactate). The pH profile of the pyruvate reduction activity was similar to
that of the pyruvate carboxylation activity; the highest pyruvate reduction activity was
observed above 90oC probably owing to its independence of COz concentration (Figs.
3.2B and 3.2D). Several studies have shown that malic enzymes from various
sources can catalyze the reduction of pynrvate to lactate (Yamaguchi, 1979; Tang and
Hsu, 1973). However, the physiological role of the archaeal malic enzyme remains
unclear. Our finding may give insight into the precise function of malic enzymes in
the unique metabolism of hyperthermophilic archaea.
Some malic enzymes are activated by NHa*and K* (Kawai et a1.,1996; Gourdon
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et a1.,2000). This was also shown to be the case for ThME. The addition of NFIa*
(10 mM) could markedly increase the carboxylation activity of ZtME by 16.1-fold
(Table 3-l). On the other hand, activation of ZftME by the addition of K* was modest,
and no synergistic effect of NH+- and K- was observed. Thus, we employed l0 mM
of NFIa+ in malate production.
Table 3-1
EfFects ofNH4+and K+concentrations on■N〔E a tivity
NFI4* (mM)
10
0
K+(mM) 5
100          11501610
10
540          1530          1600
740          1500          1690
Assays were perfolllled under the standard conditions with indicated concentrations of
NH4+and K+.
Activities were expressed as percentages ofthat observed in the absence of NH4+and
K+.
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The identification
crucial to decide the
of the active species for Z/rME-mediated carboxylation is
reaction conditions for malate production via the synthetic
the malicDalziel and Londesborough (1968) demonstrated that
germ preferably accepts dissolved COz as the carboxylation
(1979) reported that HCOI- serves as the substrate for pyruvate
pathway. Although
enzyme from wheat
species, Asami et al.
31040 07 0000
Tempnturc (oC)
47
carboxylation catalvzed bv the maize malic enzyme. To identifu the active
carboxylating species for ZfrME, NADPH oxidation in the mixture consisting of
pynrvate and ZfrME was spectrophotometrically determined at 340 nm upon the
addition of either dissolved COz or HCO3- at 15oC. Below 20oC, the interconversion
of HCOI- and COz takes more than I min; therefore, the effect of dissolved COz and
HCOr- on the initial carboxylation rate can be determined (Erb et al., 2009). As
shown in Fig. 3.3, the initial reaction rate with HCO3- as the substrate was higher than
that with CO2, suggesting that HCO:- served as the carboxylating species for TbME.
As control, both reactions were performed in the presence of carbonic anhydrase.
Carbonic anhydrase, which catalyzes the reversible interconversion of COz and HCO3-.
accelerates the equilibration between them. As expected, similar NADPH oxidation
rates were observed in the presence of carbonic anhydrase in both reactions. The
initial rate of carboxylation was dose-dependently increased by increasing HCO3-
concentration until 100 mM (Fig. 3.a).
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Fig. 3.3 Determination of carboxylating species of ZfrME-mediated malate
production. NADPH oxidation was spectrophotometrically determined at 340 nm at
15oC. To determine the carboxylating species, the reaction was started with either
dissolved CO2 (grey solid line), or HCO:- (black solid line) at l5oC, at which COz
hydration/HCOI- dehydration is slow. As control experiments, the reaction was
performed in the presence of carbonic anhydrase with dissolved COz (grey dotted line)
or HCOr-@lack dotted line).
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Fig. 3.4 Effect of HCO:- concentration on initial rate of Z&ME-mediated
carboxylation. The reaction rate with 15 mM pyruvate was monitored at different
HCO3- concentration. Buffer strength was set to 0.5 M to minimize the pH shift
caused by HCO3- addition.
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3.3.3 Elfect of HCO| concentration on reaction speciftcity
Pyruvate carboxylation catalyzed by ZftME was accompanied by lactate formation
and the carboxylation rate of ZfrME was shown to be dose-dependent on the HCO|
concentration in the solution phase (Fig. 3.a). At given pHs and temperatures, the
HCO3- concentration in the solution phase is proportional to the partial pressure of COz
(Umbreit et a1.,1957), and the equilibrated HCOI-concentration was calculated to be
85 mM at 50oC, pH 7 and aCOz partial pressure of I atm (see Appendix).
To determine the effect of HCO:- concentration on malate production, the
reactions were performed in the reaction mixtures containing 0, 21 .3, 42.5 , and 85 mM
HCOr-, which were equilibrated with Nz gas mixtures containing 0,25, and 50Yo COz
and with 100% CO2, respectively. Buffer strength was set to 0.5 M to minimize the
pH shift caused by HCO3-addition.
The author observed that the addition of equimolar amounts of the substrate and
cofactor (pyruvate and NADPH) failed to produce detectable amounts of malate
probably owing to the thermodynamically unfavorable manner of carboxylation (data
not shown). Therefore, carboxylation was carried out using TkME coupled with
GDH to regenerate the coenzyme and to shift the overall chemical equilibrium.
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Besides, HCO3- concentration was varied to investigate their effects on the reaction
specificity of Z/cME, as well as to shift the equilibrium. As expected, the formation of
lactate was largely prevented by increasing HCO3- concentration, which consequently
improved malate production (Fig. 3.5). The highest malate concentration of 0.62 mM
was obtained when 85 mM HCO:- was added to the reaction mixture at a COz pressure
of I atm.
g 21,3 42.5 85
lteHCg6nXq
Fig. 3.5 Effect of HCO:- on reaction specificity. The assay was performed at 50oC
for 5 h, and lactate (white bar) and malate (black bar) were quantified. The reaction
mixture was composed of 500 mM HEPES-NaOH (pH 7.0), l0 mM NH+CI, 0.5 mM
MnCl2, 1 mM NADPH, I mM pyruvate, I mM glucose, 0.3 U of GDH , 0.1 U of
Tb}v4E, and the indicated concentration of HCO3-.
3.3.4 Direct conversion of glucose to malate through synthetic pathway
Malate production was performed at 50oC using a mixture of heat-treated
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recombinant cells with experimentally determined amounts of enzymes to achieve a
production rate of 0.02 pmol ml-' min-' The essential amounts of enzymes required
to achieve the expected production rates were optimized as described in chapter 2 (Ye
et al, 2012). TbME activity was spectrophotometrically assessed, and the enzyme
amount to give a malate production rate of 0.02 pmol ml-l min-l was determined. An
initial pymvate concentration of 1 mM was employed owing to its relatively high K,
value for pyruvate (Fukuda et a1.,2005). Production rate remained constant during
the initial 2 h. Approximately 2.6 mM malate and 0.6 mM lactate were produced
from 1.8 mM glucose within 3 h and the malate yield was calculated to be 72%o.
After 4-h reaction, the molar yield of malate dropped down to 60% (Fig. 3.6). We
confirmed that the recombinant TbME was fully stable at 50oC for l0 h. Besides, we
had observed that the conversion rate of glucose through the chimeric EM pathway
was constant in the presence of a certain level of cofactors (Ye et a1.,2012). This
observation indicates that the thermal inactivation of the enzymes involved in
chimeric EM pathway was insignificant for at least l0 h at 50oC. Similarly,
author confirmed that the degradation of ATP and ADP was insignificant at 50oC (Ye et
a1.,2012). However, the thermal decomposition of both NADP* and NADPH was
not negligible (Fig. 6). It seems likely to have caused a decrease in the catalyic
the
the
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perforrnance of GAPN and ffrME. ATP turnover number was calculated to be 9 from
the actual ATP and ADP concentrations of the reaction mixture (0.4 mM). ATP
turnover number was defined as number of moles of the product formed per mole of
the cofactor added.
Timo {h}
Fig. 3.6 Time course of malate production through synthetic pathway. Malate
production was performed as described in the text at a glucose feeding rate of 0.01
pmol ml-r min-l and a HCO:- feeding rate of 0.02 pmol ml-r min-r. The malate,
lactate, and NADP(H) concentrations are indicated by circles, squares, and diamonds,
respectively
3.4 Discussion
In this chapter, the author consffucted a synthetic pathway, by coupling the
non-AlP-forming chimeric EM pathway with the malic-enzyme-mediated HCO3-
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fixation into pyruvate, for the direct conversion of glucose to malate (glucose + 2
HCOr- + 2 H+ ---+ 2 malate + 2 HzO; AG0': -12L4 kJ mol-'). Despite the
thermodynamical unfavorability of pyruvate carboxylation catalyzed by the malic
enzyme (AGO': +7.3 kJ mol-l), the coupling with the non-ATP-forming chimeric EM
pathway successfully shifted the overall chemical equilibrium towards malate
production. TkME was found to exhibit both pymvate carboxylation
(malate-forming) and pyruvate reduction (lactate-forming) activities; the reaction
specificity could be shifted to obtain malate as the primary product by increasing
HCOI- concentration.
From the viewpoint of practical applications, the utilization of COz in malate
production is more desirable than that of HCO3-. Thus, the direct fixation of COz into
pyruvate was attempted by sparging CO2 gas into the reaction mixture containing
TbME and GDH at 50oC. However, the system produced only 0-l mM malate from
100 mM pyruvate. This was probably due to the lower saturation concentration of
COz at higher temperatures (Mook et a1.,1974) and to the lower hydration rates of CO2
(CO2 + HzO --- HzCO:) (Dalziel and Londesborough, 1968). To increase
hydration rate, the integration of a thermophilic carbonic anhydrase, which
catalyze the interconversion between CO2 and HzCOt, would be a promising approach
the
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and is currently under investigation.
Zelle et al. rcported four natural metabolic pathways for the production of malate
from glucose: i) The first is the carboxylation of pyruvate to oxaloacetate, followed by
the reduction of oxaloacetate to malate. If pyruvate is produced through glycolysis,
this pathway involves the net fixation of CO2, resulting in a maximum theoretical
malate yield of 2 mol (mol glucose)-r ii) The second is the condensation of
oxaloacetate and acetyl-coenzyme A (acetyl-CoA) to citrate, followed by its oxidation
to malate via the tricarboxylic acid (TCA) cycle. If acetyl-CoA is generated by
pyruvate dehydrogenase, the conversion of glucose to malate via this oxidative
pathway results in the release of two molecules of CO2, thus limiting the maximum
theoretical malate yield to I mol (mol glucose)-r iii) The third is the formation of
malate from two molecules of acetyl-CoA via the glyoxylate cycle. In this alternative
oxidative pathway for malate production, the maximum malate yield on glucose is
limited to I mol mol-r owing to the oxidative decarboxylation required for acetyl-CoA
production from pyruvate. iv) The fourth is a noncyclic pathway involving
glyoxylate cycle enzymes, in which oxaloacetate is replenished by pyruvate
carboxylation. The theoretical maximum malate yield on glucose via this pathway is
1.33 mol mol-llzelle et a1.,2003). Compared with these four natural metabolic
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pathways, our chimeric pathway illustrated in Fig.3.1 can provide a theoretical
maximum yield of 2 mol of malate per mol of glucose, which is comparable to the
oxaloacetate-mediated malate production. Note that such a direct conversion can
hardly be achieved in vivo owing to the less favorable conditions for carboxylation, i.e.,
low intracellular HCO3- concentration, which lead to the thermodynamic unfavorability
of malic-enzyme-mediated carboxylation. In fact, although the inability of the
pynrvate-carboxylase-deficient mutant of Saccharomyces cerevisiae to utilize glucose
as the sole carbon source could be complemented with a cytosolic-relocalized malic
enzpe under COz atmosphere, the growth rates of the strains are considerably lower
than that of the wild-type strain (Zelle et a|.,2011).
Another important issue that should be resolved is that TbME shows preference for
NADP(H) over NAD(H) as the cofactor (Fukuda et a1.,2005). The thermostability of
NADP(H) is considerably lower than that of NAD(H) under neutral and acidic
conditions (Wu et al.,1986). The rapid degradation of NADPH at high temperatures
has restricted the application of NADPH-dependent dehydrogenases. The alteration
of the coenzyme specificity of ZftME would be an effective strategy to overcome this
limitation and achieve the long-term operation of a synthetic metabolic system.
However, the thermal lability of redox cofactors poses a simple question about the
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underlying mechanisms by which thermophiles and hyperthermophiles can solve the
problem. Further studies aimed at elucidating such mechanisms will be required not
only for the deeper understanding of the physiology of (hyper)thermophiles but also
for improving the practical applicability of synthetic metabolic engineering.
3.5 Summarry
In this chapter, a synthetic pathway for the direct conversion of glucose to malate
was constructed. The reversible carboxylation of pymvate catalyzed by a malic
enzyme derived from Z kodaknrensrs was coupled with a thermodynamic favorable
non-ATP-forming EM pathway to achieve redox balance and to shift the overall
equilibrium towards malate production. TbME was shown to exhibit both pyruvate
carboxylation and
the substrate of
pyruvate reduction activities. By increasing the concentration of
could be redirected to malateHCO:-, the reaction specificity
production. As a result, the direct conversion of glucose to malate can be achieved
with a molar yield of 60%.
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3.6 Appendix: calculated concentrations of COz, HCO3- and COr'- at 50oC
and a CO2 partial pressure of 1 atm.
The partitioning of carbon dioxide between the gas and liquid phases is dependent on
water pH, since carbon dioxide is buffered in water by the bicarbonate buffer system:
COz (g)--- COz (aq)
COz (aq) + HzO * HzCOr
Henry's law describes the solubility of an ideal
of the gas in the liquid phase is proportional to
given as
Pcoz: Ks x [H2CO3]
K: ,[H'T'], - 1.7 x 10-3[CO, l(aq)
Thus,
Pco, : Ks x [CO2 (aq)]
According to Carroll et al., at low pressures (up to l0
expressed as,
gas in the liquid phase. The solubility
the pressure of the gas over the solution,
(3)
atm), Henry's constant could be
where K11 is Henry's constant (expressed on a mole fraction basis), Pcoz is the partial
pressure of the gas (MPa), and [HzCO3] includes dissolved COz and hydrated COz in
the liquid phase. However, the dehydration is kinetically slow and only a small
fraction (approximately 0.2-1%o) of dissolved COz is actually converted to HzCOr at
equilibrium. Most of the COz remains as solvated molecular COz.
(2)
inO(H)=-6.83+1.28×104/T_3.77×106/T2+3.00×108/T3   (4)
where T is the temperature (K). According to eq. (4), the solubility of CO2 at 50oC
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(323 K) and I atm (0.1 MPa) can be calculated to be 19.8 mM.
Carbonic acid is a weak acid that dissociates in two steps.
Step 1. HzCO: (aq) * H* + HCO:-
v a[HCo3-l :4.2 x l1-j
^al - tHrco.r
Step 2. HCO3-.- H* + COr2-
K",: *_9!] = 4.g 
" 
Io-illHco3-I
where a: [H*].
The substitution of eq. (6) into eq. (5) yields
[CO2(aq)] :[H2COrl:#
(5)
(6)
(7)
Assuming that the initial concentration of carbonic acid = c, then we can derive the
stoichiometric relation.
c: [H2CO3] + [HCO3-] + [CO:'-]. (8)
Substituting this into the stoichiometric relations, we derive,
[CO.2-l - _ KarKaz'ca.+ KaTa* K21K22' (9)
[HCor-J = 
"4fffi".*, (lo)
[co2 (aq)]: [Hzcor] : a+K#k^,K*, (ll)
Assuming a temperature of 50oC and a pressure of I atm, the CO2 concentration in
water is calculated to be 19.8 mM. Thus, according to eq. (11), HCOI- concentration
can be calculated as follows.
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pH COz (mM) HCOr- (mM) CO:2-(mM)
I
2
aJ
4
5
6
8
9
l0
1l
t2
13
t4
19.8
19.8
19.8
19.8
19.8
19.8
19.8
19.8
19.8
19.8
19.8
19.8
19.8
r 9.8
8.51 x l0-5
8.51 x l0-a
8.51 x l0-3
8.51 x l0-2
8.51 x l0-t
8.51
8.51 x l0r
8.51 x 102
8.51 x 103
8.51 x l0a
8.51 x I 0s
8.51 x 106
8.51 x 107
8.51 x 108
4.09x l0-ra
4.09x l0-r2
4.09x l0-ro
4.09x l0-8
4.09x 10-6
4.09x l0-a
4.A9xft'z
4.09
4.09x 102
4.09x l0a
4.A9x106
4.09x 108
4.09x 1010
4.09x10t2
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4. Conclusions
Metabolic engineering has become a practical alternative to conventional
chemical conversion particularly for biocommodity production processes; however,
this approach is often hampered by as yet unidentified inherent mechanisms of natural
metabolism. One of the current research directions in the field of metabolic
engineering is to gain a deeper understanding of these underlying regulatory networks
by exploiting the information obtained from a variety of "-omics" analyses (Itoh et al.,
2004). By contrast, synthetic metabolic engineering provides a completely different
means to overcome this limitation by reconstituting only the pathway of interest using
thermo-tolerant biocatalvtic modules. Besides, this approach has several
advantageous, such as better process
processes by altering enzyme level.
flexibility, ease of optimization of production
Moreover, the elimination of microbial growth
and byproduct formation enables us to achieve stoichiometrical conversion and
perform thermodynamic predictions of production yield. In the case no thermophilic
enzymes are found, several evolutional approaches can be applied to increase the
thermostability of less stable enzymes (Miyazaki et a1.,2000; Wintrode et a1.,2001).
In fact, enzymes can be readily evolved for higher thermostabiliry owing to the fact
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that relatively few amino acid substitutions (l-5% of the sequence) can improve the
thermal stability of a mesophilic enzyme (Farinas et a1.,2A01). In the present study,
the author successfully constructed a non-ATP-forming EM pathway by synthetic
metabolic engineering and demonstrated its applicability for the production of desired
metabolite. The results described in each chapter can be summarized as follows:
Chapter 2 describes the construction of a non-ATP-forming EM pathway and its
applicability in the production of lactate. To be specific, a chimeric EM pathway with
balanced consumption and regeneration of ATP and ADP was constructed in vitro by
using nine recombinant E. coli strains, each one of which overproduces either one of
the seven glycolytic enzymes of T. thermophilus, the cofactor-independent
phosphoglycerate mutase of P. horilashii, or the non-phosphorylating
glyceraldehyde-3-phosphate dehydrogenase of T. kadakarensis. To demonstrate the
feasibility of the chimeric EM pathway, a NADH-dependent malate/lactate
dehydrogenase was employed to achieve the redox balance of the cofactor and direct
conversion of glucose to lactate. As a result, 6 mM glucose could be converted to 12
mM lactate within 10 h with nearlv 100% molar vield.
Chapter 3 deals with the construction of a synthetic pathway capable of direct
conversion of glucose to malate. Reversible carboxylation of pyruvate catalyzed by a
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malic enzyme (AGo': +7.3
thermodynamically favorable
consumption and regeneration
kJ mol-') was coupled with the above-mentioned
non-ATP-forming EM pathway to balance the
of redox cofactors and to shift the overall equilibrium
malate +2HzO;AGo'=towards malate production (glucose + 2 HCOI- + 2 H" ---+ 2
-121.4 kJ mol-'). Additionally, the author found that the ThME had both pyruvate
carboxylation (malate-forming) and pyruvate reduction (lactate-forming) activities.
By increasing the concentration of the substrate of HCO3-, the reaction specificity
could be redirected to the malate production. As a result, direct conversion of glucose
to malate can be achieved with a molar vield of 60%.
The concept of in vitro synthetic-pathway biotransformation is not new but its
feasibility in practical application has been largely restricted mainly owing to the
prejudice that in
biocommodities.
biotransformation is too costly for producing low-value
Howevero the comparative cost analysis between in vitro and in vivo
fermentation processes demonstrated that this interpretation is not necessarily true and
that the development of stable standardized enzyme modules will provide economical
advantageous to the use of in vitro system. Weight-based turnover number (TTNy)
in terms of kg of product per kg of biocatalyst, has been used to compare microbial
fermentation and cell-free bioconversion. Typical TTNw values for intracellular
ν′″0
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recombinant protein production by microbial fermentations range from 0.005 to 0.25
(i.e., l-50o/o cellular protein is the target recombinant protein and total cellular proteins
account for 
-50o/o of cellular weight) (Zhang et a1.,2010). Although we have not
quantified the total concentration of thermophilic enzymes used in our study, it could
be roughly estimated to be around 6 and 5 in the production of malate and lactate,
respectively (we estimated it on the basis of the presumption that the recombinant
thermophilic enzymes occupy 5Yo of the total protein of E. coli, in average).
Therefore, the performance of our system is far more effective than in vivo
fermentation processes. Meanwhile, since the performance of the in vitro enzymatic
conversion is independent of the metabolic activity of the cells, highly reproducible
reaction rates can be achieved at different reaction scales without complex process
controls (Restiawaty et a|.,201 I ).
Synthetic metabolic engineering enables a one-step preparation of highly selective
and stable biocatalyic modules via a simple heat-treatment of the recombinant
mesophiles having thermophilic enzymes. Most importantly, it is, in principle,
applicable to all thermophilic enzymes, as long as they can be functionally expressed
in the host, and thus would be potentially applicable to the biocatalytic manufacture of
anv chemicals or materials on demand.
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